[Direct answer]In the Beijing area, if any damage occurs after purchasing medication with an electronic prescription, the victim can file a claim against the seller or manufacturer. According to Article 1202 of the Civil Code of the People's Republic of China, if a product defect causes harm to others, the manufacturer shall bear tort liability; Article 1203 allows the victim to seek compensation from either the manufacturer or the seller. If the medication is sold without a prescription, the prescription review is merely a formality, or there is a lack of medication guidance, the party at fault can also be held liable according to Article 165 of the Civil Code. According to the "Supervision and Management Measures for Online Sale of Drugs" (effective from December 1, 2022), the online sale of prescription drugs must be based on a prescription and subject to review by a licensed pharmacist. It is recommended to keep the order, prescription, and medication, seal and preserve the samples as soon as possible, and apply for appraisal. For more details, please refer to the official document.Legal services for personal injury and medical disputes.

1. Problem background and typical scenarios

After the popularity of online medical consultations and online pharmacy retailing, "prescribing online and delivering to homes" has become a common way to purchase medicines, but disputes have also increased simultaneously. Typical scenarios include: platforms using the name of "electronic prescriptions" but actually generating prescriptions automatically without conducting real consultations; pharmacists' reviews being a formality and prescription drugs being sold at will; drugs being transported and stored in violation of temperature control requirements, leading to spoilage and ineffectiveness; and the sale of drugs in bulk and the substitution of health products for medicines. When handling similar cases in Beijing, the court usually reviews whether the prescriptions are genuine and valid, whether the sellers have fulfilled their obligations of review and notification, and whether there is a causal relationship between the damage and the drug defects. In cases involving the qualifications and compliance of drug operators, relevant evidence can be combined with the court's review.Intellectual property protection and corporate legal servicesReview them together.

II. Key points of contention

There are three key points of contention. Firstly, the nature of liability and the subject: If the drug is defective, product liability applies, and the manufacturer and seller can be sued separately or concurrently; if it is a medical malpractice, it falls under medical damage liability, which is borne by the prescribing medical institution. Secondly, prescription compliance: Whether the electronic prescription is issued by a qualified doctor, reviewed by a licensed pharmacist, and recorded under the patient's real name directly determines the seller's fault. Thirdly, causality: Whether the damage is caused by a drug defect, improper medication, or the patient's underlying disease requires expert appraisal and technical opinions. In practice, platforms often defend themselves by claiming that they "only provide information matching services", but if they are deeply involved in prescription issuance, payment collection, and delivery, they may still be held liable. For issues involving platform agreements and liability allocation, reference can be made to relevant provisions.Legal services for corporate commercial and contract disputesAnalyze the effectiveness of the clauses.

III. Professional analysis by Henglue Law Firm

Based on practical observations in handling drug and medical disputes, the key to resolving online pharmaceutical disputes lies in "assigning responsibility to specific parties". According to Article 1203 of the Civil Code, the infringed party may seek compensation from either the producer or the seller, and the party making the initial payment may subsequently seek recourse against the party at fault, which reduces the subject selection obstacles for patients. According to Article 1207, if a product is known to be defective but is still produced and sold, causing serious harm, the victim may claim corresponding punitive damages. At the same time, the "Supervision and Management Measures for Online Sale of Drugs" (effective December 1, 2022) require that prescription drugs be sold online with a prescription, implement a real-name system, and conduct prescription review. If the seller violates the review obligation, it constitutes negligence. Henglue Lawyers usually recommend the following: First, fix the order, electronic prescription, payment records, and chat records as soon as possible, keep the original packaging of the unused drugs and apply for sample preservation; check the seller's "Drug Business License" and the platform's filing information; apply for an appraisal of the causality between the damage and the medication; and, if necessary, list both the seller and the producer as defendants to avoid mutual recrimination. If the case involves suspected crimes of counterfeit or substandard drugs, it can be referred to the relevant authorities for further handling.Criminal defense and legal services for criminal case filingRespond synchronously.

IV. Practical suggestions and legal basis

The core basis is Article 1202 (Product Liability of Producers), Article 1203 (Right of the Infringed Party to Choose One of the Remedies and Seek Recovery), Article 1207 (Punitive Damages), Article 1165 (Liability for Fault), and Article 1179 (Scope of Compensation for Personal Injury) of the Civil Code of the People's Republic of China (effective January 1, 2021); the principles of drug operation and online sales stipulated in the Pharmaceutical Administration Law of the People's Republic of China (amended on August 26, 2019 and effective December 1, 2019); and the requirements for selling prescription drugs with prescriptions, prescription review, and real-name system stipulated in the Supervision and Management Measures for Online Sale of Drugs (effective December 1, 2022). Practical suggestions include: retaining orders, electronic prescriptions, payment receipts, and actual drugs; sealing and preserving samples and applying for appraisal; verifying the seller's drug operation qualifications; fixing evidence of causality between damage and medication; and filing complaints and reports with drug regulatory authorities while simultaneously claiming civil compensation. For cases involving the recovery of funds, follow-up procedures can be initiated accordingly.Legal services for creditor-debtor disputes and enforcement casesOther details shall be subject to the currently effective laws and regulations and judicial rulings.

5. Henglu Law Firm's Advice

The convenience of online drug purchases is accompanied by a longer chain of responsibilities and the need to collect evidence as soon as possible. Three tips: First, keep the original packaging and instructions for the drugs, and do not open and discard them, otherwise it will be difficult to prove the defects. Second, electronic prescriptions do not exempt sellers from liability. Sellers still have the obligation to review and provide medication guidance. Selling drugs illegally constitutes a breach of duty. Third, it is important to distinguish between "product defects" and "medical errors". In the former case, you can claim compensation from the seller; in the latter case, the prescribing institution should bear responsibility. The legal procedures and evidentiary focus are different for the two cases. If the case involves counterfeit or substandard drugs or involves large amounts of money, you can simultaneously report it to the drug regulatory authorities and public security organs to form a parallel pressure involving civil, administrative, and criminal litigation. For cases involving serious harm and long-term treatment, it is recommended to promptly entrust professional lawyers to fix evidence and assess the scope of compensation. If you need help, you can contact us through the following channels:Special services and legal services for other casesObtain support.

VI. Frequently Asked Questions

Q1: If there are problems with purchasing medication through electronic prescriptions, can patients or purchasers win the lawsuit?

The ability to obtain compensation depends on whether the defect, fault, and causality exist. If the drug itself has a defect, according to Articles 1202 and 1203 of the Civil Code, the claimant can choose to sue either the producer or the seller, without having to first prove the seller's fault. If the drug is not defective, but the seller fails to sell the drug based on a prescription, fails to perform the obligation of prescription review or medication guidance, and causes damage, then the seller shall be held liable according to Article 1165 based on fault. Therefore, the key lies in distinguishing between "drug defects" and "medication errors" through appraisal. If the seller's qualifications are compliant, the prescription is genuine, and the damage is caused by the claimant's own underlying disease, the claim is unlikely to be supported. It is recommended to first fix the evidence and conduct technical appraisals, and then evaluate the feasibility of litigation.

Q2: What evidence do I need to prepare for online pharmacy disputes?

The core evidence includes: purchase orders, electronic prescriptions, and payment records (to prove the transaction and the source of the prescription); the actual drugs and their complete packaging, instructions, and batch numbers (to prove product identity and defects); platform pages, customer service chat records, and medication guidance records (to prove the fulfillment of the obligation to provide information); medical records, diagnosis certificates, and examination reports (to prove the consequences of the damage); the seller's "Pharmaceutical Business License" and platform filing information (to prove the operating qualifications); and expert opinions on the causality between the damage and the medication. The evidence should be organized around the "transaction—product identity—defects or faults—damage causality" framework. It is crucial to preserve the original packaging of the drugs and not to discard it after use, otherwise, it will be very difficult to provide evidence.

Q3: What are the approximate attorney fees and litigation costs for such disputes?

The litigation fees shall be paid in accordance with the "Measures for the Payment of Litigation Costs", and shall be paid in stages based on the amount of the claim, with the losing party bearing the cost or sharing it according to the proportion of the victory and defeat; in cases of product liability and medical damage, appraisal fees are often required, and the appraisal fees shall be paid in advance by the applicant and ultimately shared according to the proportion of liability. There is no unified government pricing for attorneys' fees, which are usually charged on a per-case basis, a percentage of the amount of the claim, or on an hourly basis, subject to the terms of the contract; in cases involving personal injury, it is prohibited to stipulate risk-sharing agreements in violation of regulations. It is recommended to calculate the items and amounts of compensation that can be obtained before suing, and to weigh them together with the appraisal fees, litigation fees, and attorneys' fees; for cases with a small amount of compensation and no major disputes, it is preferable to resolve them through drug supervision complaints and negotiations to reduce the cost of protecting rights.

Q4: How long does it usually take to handle online pharmaceutical sales disputes?

The timeframe depends on the complexity of the case and the path taken. Filing a complaint or report with the drug regulatory authorities is usually relatively quick, but administrative handling does not directly determine civil compensation; negotiations or mediation typically take several weeks to months. For cases entering civil litigation, the first-instance ordinary procedure generally concludes within six months and the summary procedure within three months; if product defect appraisal or causality appraisal is required, the appraisal period of several months will significantly prolong the overall timeframe, and the appeal process will add about three months. After the judgment takes effect, if the other party fails to perform their obligations, it is necessary to apply for enforcement, and the enforcement period depends on the situation of property investigation and control. It is recommended to apply for property preservation concurrently during the litigation to shorten the actual time to obtain compensation.

Q5: If there are problems with purchasing medication using an electronic prescription, what should I do first?

It is recommended to handle the matter in five steps: First, immediately suspend the use of the remaining drugs and keep the original packaging, instructions, and batch numbers, and do not discard them; Second, take screenshots and save the order, electronic prescriptions, payment records, and chat logs with customer service to fix the transaction and provide evidence; Third, seek medical treatment as soon as possible and keep medical records, diagnoses, and expense receipts. If necessary, apply for sealing and preservation of samples and appraisal; Fourth, verify the seller's drug business qualifications and prescription review, and file a complaint and report to the drug regulatory authorities; Fifth, based on the appraisal conclusion, choose to claim compensation from the seller or producer. If no agreement is reached, file a lawsuit within the statute of limitations. Throughout the entire process, it is necessary to keep communication records and, if necessary, engage professional lawyers as soon as possible to evaluate and negotiate.

This article is written based on the common judicial interpretations in the Beijing area. If the case occurs in other regions, it is recommended to consult local lawyers to verify the regional differences.

If you are facing similar problems, it is recommended that you consult a professional lawyer as soon as possible with the evidence materials, so as to avoid missing the statutory time limit.Personal injury legal services·Beijing Henglu Law Firm

Disclaimer: This article is compiled based on the current effective laws and regulations and public adjudication rules, and is for general reference only. It does not constitute a formal legal opinion on specific cases. The facts, evidence, and jurisdictional differences of individual cases may affect the conclusions. If you encounter disputes, please consult a practicing lawyer in time.